SCHEMBL18680903

SCHEMBL18680903

CCSc1ccc(OC)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
CYP2E1 P05181 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C8 P10632 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2B6 P20813 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 3/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HTT P42858 1/20 0.41
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
HPGD P15428 3/20 0.40
NPY1R P25929 1/20 0.39
NPY2R P49146 1/20 0.39
TAAR1 Q96RJ0 2/20 0.39
KIF11 P52732 2/20 0.38
CPS1 P31327 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3480415 0.78 NPC1 (0.45) CYP1A2CYP3A4KDM4EMAPTALDH1A1
SCHEMBL22492226 0.78 ALDH1A1 (0.49) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL779536 0.76 DDR1 (0.38) ALDH1A1NPC1RAB9ACA2DDR1
SCHEMBL29722933 0.76 DDR1 (0.38) ALDH1A1NPC1RAB9ACA2DDR1
SCHEMBL25122311 0.76 CYP1A2 (0.44) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL16676451 0.75 ADRA1A (0.45) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL28072988 0.75 CYP1A2 (0.41) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL13461857 0.75 NPC1 (0.37) CYP1A2MAPTHPGDKIF11NPC1
SCHEMBL11896544 0.74 MEN1 (0.51) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL16676238 0.74 NQO2 (0.44) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501236-B1 N-[2-fluoro-3-(4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-4-benzenesulfonamide derivatives as Raf protein kinase modulators for the treatment of cancer PLEXXIKON INC (US) 2017-03-29 EP disclosed